Valneva Commences Rolling Submission To U.K. For COVID-19 Vaccine

(RTTNews) - Valneva SE (VALN) said that it commenced rolling submission, for initial approval of its COVID-19 vaccine candidate, VLA2001, with the Medicines and Healthcare products Regulatory Agency in the United Kingdom.

The company believes that initial approval could be granted before the end of 2021.

VLA2001 is a whole virus, inactivated, adjuvanted vaccine candidate and is the only vaccine candidate of this type currently in clinical trials in Europe, Valneva said in a statement.

In September 2020, Valneva announced a collaboration with the UK Government, which has the option to purchase up to 190 million doses through 2025. So far, the UK Government has ordered 100 million doses for supply in 2021 and 2022.